CytoDyn to Hold Webcast to Provide a Quarterly Company Update :: CytoDyn Inc. (CYDY)
VANCOUVER, Wash., Sept. 19, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for…